INTRODUCTION
During myelopoiesis, self-renewing hematopoietic stem cells (HSCs) differentiate into broadly myeloid-committed progenitors (common myeloid progenitors [CMPs] ), which further differentiate into two major branches: polymorphonuclear phagocytes, comprising granulocytes as well as mast cells, and mononuclear phagocytes, comprising monocytes, macrophages, and dendritic cells (DCs) (Hume, 2008; Geissmann et al., 2010; Liu and Nussenzweig, 2010; Kushwah and Hu, 2011) . Although the separation process of granulocytes from monocytes is relatively well studied, it is poorly understood how myeloid precursors specify into DCs. DCs are a heterogeneous cell population with a critical role in immune response and self-tolerance (Steinman and Cohn, 1973; Merad and Manz, 2009 ). In the current model, DCs are replenished from macrophage-DC progenitors (MDPs) harboring both macrophage and DC potential (Fogg et al., 2006; Geissmann et al., 2010) . MDPs are thought to directly yield common DC progenitors (CDPs) (Onai et al., 2007) . CDPs are a source of both conventional DCs (cDCs) and plasmacytoitic DCs (pDCs).
A number of transcription factors, such as PU.1, SpiB, Tcf4 (E2-2), Batf3, Id2, and Irf8 (also known as interferon consensus sequence binding protein [ICSBP] ) have been implicated in DC development (Watowich and Liu, 2010; Carotta et al., 2010; Schotte et al., 2004; Cisse et al., 2008; Hildner et al., 2008; Hacker et al., 2003) . However, it is currently unknown if and how these factors drive the initiation of DC commitment from CMPs. Therefore, we aimed to decipher transcriptional mechanisms initiating DC fate selection. For this purpose, we chose to explore the molecular function and transcriptional regulation of the Irf8 gene. Irf8 -/-mice have profoundly depleted pDCs and CD8a + cDCs (Tsujimura et al., 2002 (Tsujimura et al., , 2003b la Sala et al., 2009 ) but generate more neutrophils and develop a syndrome that resembles human BCR-ABL + chronic myeloid leukemia (Holtschke et al., 1996; Schiavoni et al., 2002; Tsujimura et al., 2003a; Ginhoux et al., 2009) . Moreover, mutations inactivating the IRF8 DNA binding domain have recently been shown to cause human DC immunodeficiency (Hambleton et al., 2011) . Here, we generated Irf8 reporter mice and identified the progenitor stage at which DC lineages separate from alternative myeloid lineages. We show that Irf8 is required for the production of this progenitor and reveal that the initiation of Irf8 expression is controlled by PU.1-induced higher-order chromatin remodeling. and S1B) (Tsujimura et al., 2002 (Tsujimura et al., , 2003b la Sala et al., 2009) . To pinpoint the differentiation stage at which Irf8 is required during DC development, we introduced the Cx3cr1 GFP reporter into the Irf8 -/-background, which was shown to mark MDPs as the initiation stage of mononuclear phagocyte commitment (Jung et al., 2000; Fogg et al., 2006) . Whereas Lin À /Sca-1 + /c-kit + cells (LSKs) and granulocyte and macrophage progenitors (termed GMPs* in order to indicate that they are Cx3cr1 À ) were normal in Irf8 -/-mice, CMPs* (also Cx3cr1 À ) and CDPs were reduced (Figures 1A, 1B, and S1C). However, surprisingly, the Cx3cr1 reporter revealed a profoundly expanded MDP population. We confirmed this expansion by using M-CSFR as a second marker for the identification of MDPs (termed MDPs* in order to distinguish them from Cx3cr1 + MDPs) because M-CSFR expression has been shown to overlap with Cx3cr1 GFP expression (Waskow et al., 2008 ) ( Figure S1D ). Next, we explored the functional po- -/-progenitors, the expression of 104 genes was increased, and the expression of 117 genes was decreased by more than 2-fold (p < 0.05). Unbiased categorization of the differentially expressed genes for different phagocyte lineage-associated gene signatures ( Figure S1F and Tables S1-S4) revealed that the Irf8 +/+ progenitors expressed many DC and/or macrophage genes but few neutrophil genes (Figures 1E and 1F) . A loss of Irf8 reversed this distribution in that the expression of DC and shared DC and macrophage genes were reduced, but the expression of neutrophil genes was enhanced. Notably, Irf8 deletion had only minimal effects on macrophage gene expression. Moreover, analysis of the expression of the entire signature gene sets within the Irf8 +/+ and Irf8 -/-progenitors revealed that Irf8 deficiency resulted in an overall weaker expression of the DC signature, a stronger expression of the neutrophil signature, and a largely unchanged expression of the macrophage signature ( Figure 1G ). Among the Irf8-controlled target genes were transcription factors (e.g., Klf9, Mef2d, and Runx2), chemokine receptors (e.g., Ccr1and Ccr2), and interferon-and toll-like-receptor-associated genes (e.g., Ifngr1 and Ly86) as well as metalloproteinases (e.g., Mmp8) (Table S5) . We conclude that Irf8 is important for MDP transition to the CDP by orchestrating the shift of neutrophil-to-DC gene expression programming. Irf8 deficiency did not change the MDP macrophage program, indicating that Irf8 also acts as a transcriptional separator of the DC from macrophage potential.
Tracing Irf8 Expression by Generation of Reporter Mice
Because the data showed that Irf8 ablation functionally and transcriptionally separated DC from macrophage potential of MDPs, we reasoned that tracing Irf8 expression at the single-cell level would make the identification of earliest DC-committed progenitors possible. Therefore, we engineered an Irf8 reporter mouse (Figure 2A) , resulting in the expression of a wildtype (WT) Irf8 protein and the VENUS reporter from a bicistronic messenger RNA (mRNA). In addition, we inserted loxP sites around a cis-regulatory element 50 kb upstream of the Irf8 transcription start site (see below) to enable its conditional removal from the PAC. We generated stable transgenic lines from three independent founder mice (lines 52, 87, and 88) with complete integration of a structurally intact PAC DNA in two, three, and four copies, respectively ( Figures S2A-S2C) . Importantly, the PAC transgenes neither enhanced Irf8 expression over WT levels nor caused any detectable phenotypic abnormalities ( Figures  S2D and S2E 
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in vitro at 0 hr and 24 hr in the presence of 10 ng/ml IL3, 10 ng/ml IL6, and 50 ng/ml SCF. An FcgRII/III + gate has been added here to avoid cell-sorting contaminations with LSKs. See also Figure S3B . (Onai et al., 2007) . Both CD8a + and CD8a À pDCs were produced by CDPs and Irf8 VENUS+ MPs at similar frequencies, suggesting that both progenitors are within the same differentiation pathway ( Figure S4C ). Furthermore, we confirmed a lack of Irf8 VENUS+ MP differentiation potential into macrophages by the absence of F4/80, MOMA-1, MARCO, and SIGNR1 expression on VENUS + donor-derived splenocytes ( Figure S4D ). Moreover, we corroborated DC- 
A Distal Enhancer Drives Myeloid Irf8 Promoter Activity
The data above indicated that the onset of myeloid Irf8 expression phenotypically marks and functionally determines the developmental stage of DC lineage selection in the BM. To decipher regulatory mechanisms preceding DC fate choice, we explored how Irf8 expression is initiated. Given that lineage-specific gene expression is primarily orchestrated through genedistal regulatory elements (Heinz et al., 2010) , we computationally identified a number of different evolutionarily conserved noncoding sequences (CNSs) upstream of Irf8 ( Figure 5A ). We performed reporter assays in stably transfected RAW264.7 myeloid cells and NIH 3T3 fibroblasts to test whether these CNSs were able to enhance the activity of the Irf8 proximal promoter in chromatin context. Both the Irf8 promoter alone and the promoter in combination with the À38 kb or À16 kb CNSs were unable to drive reporter gene expression. However, the addition of the À11 kb CNS led to a 20-fold increase in promoter activity in RAW264.7 cells, and the addition of the À50 kb CNS increased the activity 750-fold ( Figure 5B ). No enhancer function was observed in NIH 3T3 cells.
The À50 kb Enhancer Controls Irf8 Expression in MDPs In Vivo Because the À50 kb CNS displayed the highest enhancer activity in vitro, we tested whether this element was required for Irf8 expression in vivo. We modified the Irf8 VENUS reporter PAC by flanking a 2.2 kb fragment containing the À50 kb CNS with loxP sites and generated transgenic animals (see above).
We crossed two of these transgenic lines (87 and 88) with CMV-cre deleter animals (Schwenk et al., 1995) to generate a germline deletion of the À50 kb element (designated Irf8 VENUSÀ50kbD mice) ( Figure 5C ). We confirmed proper excision, copy number maintenance, and genomic integrity of the Irf8 VENUSÀ50kbD transgenes in the resulting offspring ( Figures   S5A-S5C ).
Irf8
VENUSÀ50kbD mice demonstrated a tight cell-type-and developmental-stage-specific requirement of the À50 kb enhancer for Irf8 expression. Deletion of the À50 kb enhancer decreased VENUS expression only mildly in HSCs and MPPs (both included in the LSK fraction), B cells, and pDCs more strongly in CD8a + cDCs and most profoundly in MDPs* ( Figures   5D, 5E, and S5D) . Next, we explored the functional relevance of the À50 kb element for MDP* formation by introducing the Irf8
VENUSÀ50kb+ or Irf8
VENUSÀ50kbD transgenes into the Irf8-deficient background.
Importantly, the Irf8 VENUSÀ50kb+ transgene completely restored normal Irf8 -/-MDPs* ( Figure 5F ). In contrast, the Irf8 VENUSÀ50kbD transgene had 54% less efficient restoration capacity. Altogether, genetic experiments in mice provide in vivo evidence for a specific role of the À50 kb element in the control of Irf8 expression in MDPs.
Higher-Order Chromatin Structure Remodeling at the Irf8 À50 kb Enhancer An important question was why the À50 kb enhancer had such a specific effect on Irf8 expression in DC progenitors. We addressed this issue by exploring the higher-order chromatin structure at the Irf8 locus using chromosomal conformation capturing (3C). First, we screened the Irf8 upstream CNSs for spatial threedimensional contacts with the proximal Irf8 promoter region in RAW264.7 cells. We observed that the À50 kb enhancer and the À16 kb CNS, but not the À38 or À11 kb CNSs, were in spatial proximity with the Irf8 promoter, thus indicating a specific activating chromatin looping architecture at the Irf8 locus ( Figure 6A) .
To corroborate the observation that the À50 kb enhancer-toIrf8 promoter contact existed in primary cells, we used a quantitative 3C (q3C) protocol on FACS-sorted cells. Indeed, the À50 kb enhancer was found in physical contact with the Irf8 promoter in MDPs* but is not found to be in physical contact in MPs ( Figure 6B ). Moreover, comparison across cell types demonstrated that À50 kb enhancer contact with the Irf8 promoter was strongest in MDPs* but decreased thereafter in their cDC, macrophage, and pDC progeny and was undetectable in B cells ( Figure 6C) . Thus, the À50 kb enhancer was brought into physical contact with the Irf8 gene by tightly controlled remodeling of its higher-order chromatin structure. The dynamics of this remodeling closely paralleled the onset of Irf8 expression during Crosslinked chromatin was digested with NcoI (N, each line represents an NcoI restriction site) and amplified by nested PCR, as depicted at the top (bold arrows). Nonligated RAW264.7 chromatin served as a negative control, and randomly ligated NcoI Irf8-PAC fragments were positive controls. PCR amplification of self-ligated NcoI Irf8 promoter chromatin fragments (circle) by two outside-facing primers annealing within the promoter anchor primers served as a digestion and ligation efficiency control. PCR amplification with two primers that annealed within the NcoI À50 kb enhancer genomic DNA (gDNA) fragment served as input control. (B and C) q3C showing À50 kb to Irf8 promoter spatial proximity in flow-sorted cell populations. All data were normalized to total gDNA content within an NcoI restriction fragment. Normalization to looping at the Gapdh locus as housekeeping loop (Spilianakis et al., 2005) myeloid differentiation and, thus, provided an explanation for the specific effect of À50 kb enhancer deletion on DC progenitors in mice.
PU.1 Binding Is Necessary for À50 kb Enhancer Activity and Induces Chromatin Remodeling
A computational motif search identified two directly adjacent PU.1-binding consensus motifs that were highly conserved among vertebrate species ( Figure 7A) . Indeed, PU.1 occupied these sites in primary DCs but did not occupy these sites in B cells ( Figure 7B ). PU.1 occupancy was associated with cell-type-specific H3K9 acetylation, indicating a transcriptional regulatory activity of the À50 kb element in DCs. In the RAW264.7 cell-line model, mutations in either one of these PU.1-binding sites or knockdown of PU.1 by small hairpin RNA (shRNA) diminished À50 kb enhancer activity as well as endogenous Irf8 expression ( Figures 7C, 7D , and S6A). PU.1-GFP. Cells were kept in liquid culture for 8 days with 100 ng/ml Flt3L and were gated on GFP-expressing cells for analysis. n = 3 replicates per condition were analyzed. **, p % 0.005 and ***, p % 0.001.
To investigate whether PU.1 controls chromatin looping of the À50 kb enhancer to the Irf8 promoter, we performed q3C assays in PU.1ER cells and found that PU.1 induction rapidly led to a marked increase in looping frequency ( Figure 7E ).
À50 kb Enhancer Chromatin Structure Remodeling
Requires a High PU.1 Level Intriguingly, although the expression of both Irf8 and PU.1 increased to similar levels in MDPs*, the expression of Irf8 was absent in MPs, whereas the expression of PU.1 was low but readily detectable in MPs (Figure 7F ), suggesting that high PU.1 levels are required to trigger Irf8 transcription. To directly test this, we quantified Irf8 expression in myeloid progenitors from PU.1 hypomorphic mice that expressed PU.1 at a 5-fold lower level than the corresponding WT cells (Rosenbauer et al., 2004) . Indeed, these progenitors showed almost a complete lack of Irf8 transcripts, indicating that the reduced PU.1 level provided by the hypomorphic alleles was insufficient for Irf8 expression ( Figure 7G ). In line with this, shRNA-mediated gradual reduction of PU.1 levels in the RAW264.7 model impaired À50 kb enhancer-to-Irf8 promoter contact formation ( Figure 7H ). Altogether, these data indicate that PU.1 can function as a concentration-dependent trigger of Irf8 chromatin remodeling and transcription.
PU.1 Fails to Drive DC Differentiation in the Absence of Irf8 PU.1 is known to induce DC differentiation (Carotta et al., 2010; Guerriero et al., 2000 restoration rescued the capacity to produce both DC populations ( Figures 7I, S6E , and S6F). This result indicates that PU.1 requires the presence of Irf8 to induce DC differentiation.
DISCUSSION
DCs are related to, but clearly distinct from, macrophages (Merad and Manz, 2009; Geissmann et al., 2010) , and the identification of cellular precursors of the DC lineage has been the focus of intense research (Ginhoux et al., 2009; Fogg et al., 2006; Manz et al., 2001; Carotta et al., 2010; Liu et al., 2009; Waskow et al., 2008) . Taking advantage of a newly generated Irf8 reporter mouse, we report a distinct Irf8-expressing subfraction of the MDP (Fogg et al., 2006) . This Irf8 VENUS+ population had the exclusive capacity to differentiate into DCs, but not into monocytes or macrophages, in vivo. Although the cDC potential of Irf8 VENUS+ MPs was strong, the pDC potential was weaker than that of CDPs. One likely explanation for this difference could be that Irf8 VENUS+ MPs require more time than CDPs to fully replenish pDCs. This, along with their higher c-kit level, supports the idea that Irf8 VENUS+ MPs reside upstream of CDPs. However, the question of whether Irf8 VENUS+ MPs are a separate population or whether they overlap with the earliest CDPs requires further investigation. In any case, the identification of Irf8 VENUS+ MPs as an initial DC precursor within the formerly identified MDP population is instrumental in deciphering the earliest molecular events initiating DC development. Irf8-reporter-based marking of this early DC stage is associated with functional Irf8 dependency in the production of DC progenitors. MDPs isolated from Irf8 -/-mice had maintained macrophage and monocyte differentiation capacity but completely lacked DC potential in vitro. A recent study suggested that Irf8 is required for the production of DC progenitors and for the restriction of GMP expansion (Becker et al., 2012 
Irf8
-/-MDPs showed a lower expression of DC-associated genes but a higher expression of neutrophil-associated genes and an unchanged expression of macrophage-associated genes. This finding indicated that the initiation of DC differentiation choice requires an active, Irf8-dependent shift from neutrophil-to-DC gene expression in MDPs. In light of these data, it appears most likely that the excessive production of neutrophils leading to the development of granulocytic leukemia in Irf8 -/-mice may be the result of this DC-to-neutrophil ''conversion'' of the MDP. It will be interesting to see whether a similar mechanism also underlies the development of IRF8-mutated human DC immunodeficiency, which can be accompanied by high neutrophil counts as well (Hambleton et al., 2011) . A chromatin-based mechanism driving the molecular commitment of early myeloid progenitors toward DC differentiation has remained elusive. Here, we were able to pinpoint a region located 50 kb upstream of the Irf8 gene as the major enhancer driving Irf8 expression during DC progenitor formation in vivo. Deletion of the À50 kb enhancer from the engineered Irf8 PAC led to reduced reporter gene expression in MDPs, but not in stem cells, pDCs, or B cells. Accordingly, DC progenitor development was impaired in the absence of the À50 kb enhancer.
Different models of how distal regulatory elements communicate with proximal gene regulatory regions have been proposed (Wittkopp and Kalay, 2012; Bulger and Groudine, 2011) . One of these models suggests that enhancers are placed in physical proximity to promoters through chromosomal looping (Heermann, 2011) . Indeed, on the basis of 3C technology, there are now a number of examples known that support the looping model (Palstra et al., 2003; Tolhuis et al., 2002; Apostolou and Thanos, 2008; Spilianakis et al., 2005; Ling et al., 2006) . We found that looping of the À50 kb enhancer to the Irf8 promoter occurred with high specificity with regard to the lineage and developmental stage and, at least in a cell-line model, required PU.1 as a coordinator. Although it is not yet clear whether PU.1 controls Irf8 chromatin looping directly, our findings suggest a concentration-dependent model in which high PU.1 amounts are required to drive Irf8 locus looping and transcription. Such a model is supported by the recent finding that high PU.1 levels are also needed to drive Flt3 expression in cDC progenitors (Carotta et al., 2010) . Although our retroviral transduction assays have shown that PU.1 requires Irf8 as a downstream target to drive DC development, Irf8 could not substitute PU.1 in DC differentiation (see Figure 7A ) (data not shown). Again, this is similar to the inability of Flt3 to rescue PU.1-deficient DC production (Carotta et al., 2010) . Altogether, these results suggest that PU.1 controls multiple independently acting molecular pathways to drive DC development. This idea is supported by our results showing that PU.1 controls Flt3 expression independently of Irf8 (data not shown).
In summary, we have isolated an initial Irf8 + DC progenitor. In this progenitor, Irf8 transcriptionally organizes the separation of the DC program from that of other myeloid lineages, including the monocytic program. PU.1 induces Irf8 expression by remodelling its higher-order chromatin configuration to loop a distant cis-enhancer into physical proximity to the Irf8 promoter.
EXPERIMENTAL PROCEDURES
Mice and Cell Lines All mice in this research were studied on a C57Bl/6 background. C57Bl/6 wildtype mice were from Charles River Laboratories. Irf8 À/À and URE À/À mice were generated as described before (Holtschke et al., 1996; Rosenbauer et al., 2004) . Irf8 VENUS PAC reporter mice were generated by pronuclear injection of the engineered murine Irf8-PAC ( Figure S1A ) into WT C57Bl/6 fertilized oocytes. Injection was conducted at the Max Planck Institute of Molecular Cell Biology and Genetics. PAC + animals were identified by FACS and PCR (primers are available on request). Three independent PAC lines were established and used for this study. Two of these lines were bred to CMV-Cre deleter mice (Su et al., 2002) , leading to the excision of the loxP-flanked À50 kb element. All mouse experiments were approved by the local authorities according to the German Federal Animal Protection Act. RAW264.7, NIH 3T3, 416B, PU.1 -/-ERT-PU.1, and PU.1 -/-cell lines were cultured as described before (Leddin et al., 2011; Walsh et al., 2002) .
Flow Cytometry and Cell Sorting
Single-cell suspensions from indicated organs were analyzed by flow cytometry on a BD LSRFortessa cell analyzer (BD Biosciences). Cell sorting was performed on a FACSAria (BD Biosciences) equipped with an UV laser. Prior to flow sorting of BM precursors, lineage-associated cells were manually depleted after being incubated with CD3, CD4, CD8a, B220, CD19, CD11b, CD11c, and/or Gr-1. Nonspecific binding was reduced where applicable by preincubation with unconjugated antibody to FcgRII/III (2.4G2). Propidium iodide was used for the exclusion of dead cells. Cell-cycle status was determined by staining with Hoechst 33342 stain according to standard protocols.
In Vitro Colony-Forming Assays Flow-sorted cells (1 3 10 3 ) were seeded in MethoCult (M3234, STEMCELL Technologies) in triplicate. Supplements were treated with M-CSF (10 ng/ml) alone or a cocktail of SCF (50 ng/ml), IL-3 (10 ng/ml), IL-6 (10 ng/ml), and either GM-CSF (10 ng/ml), FLT3 ligand (50 ng/ml or 100 ng/ml), or a combination of both (all from Peprotech). Alternatively, MethoCult (M3334) supplemented with SCF (50 ng/ml), IL-3 (10 ng/ml), IL-6 (10 ng/ml), and erythropoietin (3 U/ml) was used. Individual colonies (defined as containing more than 50 cells) were scored with an inverted light microscope 7-10 days after plating. For the examination of morphology, cells were centrifuged onto glass slides and stained with May-Grunwald-Giemsa, as described before (Fogg et al., 2006 ) were sorted from the spleens of three independent pools of C57Bl/6 WT mice, each consisting of three animals at the age of 8-12 weeks. RNA was extracted according to the RNeasy Micro Kit (QIAGEN) protocol. High-quality RNA (Rin > 8.9) was assessed by employing the Agilent 2100 Bioanalyzer. For linear amplification of RNA, a strategy of two rounds of reverse transcription followed by T7 promoter-dependent in vitro transcription was applied with the Ovation Pico WTA System (NuGEN) according to manufacturer's instructions. For each sample, 10 mg of amplified RNA sample was labeled and hybridized in triplicate to a 24-slide cartridge Affymetrix Mouse Genome 430 2.0 Array according to the manufacturer's instructions.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed employing the LowCell# ChIP Kit (Diagenode). The antibodies used in this study included anti-PU.1 (T-21X, Santa Cruz Biotechnology), anti-IgG (Millipore, , and anti-acetyl-histone H3 (Millipore, . Immunoprecipitates were quantified with SYBR Green quantitative PCR (qPCR) on a 7300 Real-Time PCR System (Applied Biosystems). Results were calculated as percentage of the input sample, and nonspecific IgG control is shown. Primer sequences are available upon request.
Chromosome Conformation Capturing 3C was essentially conducted according to Dekker et al. (2002) . In brief, chromatin of 1 3 10 7 cells was crosslinked by a 10 min treatment with 5.4% formaldehyde followed by quenching with glycine and digestion with NcoI (New England Biolabs; 800 U, treated overnight). A fraction was removed as a noligation control; the remaining sample was diluted 45 times and religated with T4 DNA Ligase (NE Biolabs). For the analysis of ex vivo populations 1 3 10 5 flow-sorted progenitor cells, we applied a protocol by Dostie and Dekker (2007) and made minor modifications according to Staber et al. (2013) . 3C material was analyzed by nested PCR or by qPCR with a TaqMan probe spanning the NcoI site between the Irf8promoter fragment and the À50kb enhancer. Relative crosslinking frequencies were calculated after normalization to total DNA content as quantified at the À50 kb enhancer site. Additionally, relative crosslinking frequencies were calculated after normalization to chromosomal looping at the Gapdh locus, as described before (Spilianakis et al., 2005) . qPCR reactions were performed in triplicate and each experiment was repeated independently up to three times. Primers and probes were validated employing the digested and religated Irf8-PAC DNA. Digestion efficiency was calculated as in Hagè ge et al., (2007) . Only samples with digestion efficiency > 90% were used. Sequences are available upon request.
Cell Transfections and Luciferase Assays
Stably transformed reporter cell lines were generated by electroporation in RAW264.7 and NIH 3T3 cells with a Gene Pulser Xcell (Bio-Rad). PvuI-linearized reporter plasmids were coelectroporated with a plasmid carrying a puromycin resistance gene. The cells were subsequently kept under puromycin selection for 3 weeks. For the expression of firefly luciferase, 5 3 10 5 cells of stably transformed pools or single clones were analyzed with the Dual-Luciferase Reporter Assay System (Promega) according to the recommendations of the manufacturer. RAW264.7 cells were transfected with shRNA-GFP constructs (see Supplemental Information). GFP + cells were sorted 48 hr after transfection, and 5 3 10 5 cells were analyzed with the Dual-Luciferase Reporter Assay System.
Statistical Analysis
Unpaired Student's t test was carried out to determine the statistical significance of experimental results. All experiments shown were replicated at least two to three times with similar results, unless indicated differently in the figure legends.
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